Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Wellbeing Digital Sciences Inc (EM) KONEF

Healthcare Psychedelics
Wellbeing Digital Sciences Inc., a next generation wellness company, focuses on ketamine assisted therapy and psychedelic medicines through operating healthcare clinics in North America. The company was formerly known as KetamineOne Capital Limited and changed its name to Wellbeing Digital Sciences Inc. in January 2022. Wellbeing Digital Sciences Inc. was founded in 2017 and is headquartered in Vancouver, Canada.


EXPM:KONEF - Post by User

Wellbeing Digital Sciences Inc (EM)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(4)
•••
  • ENEMENEMYNEMOX
Post by ENEMENEMYNEMOon Nov 02, 2022 7:43pm
287 Views
Post# 35068269

Unbelievable

Unbelievable

So the only thing they had that could make them money they have now sold. SP  crashed when they announced a potential sale of the psilocybin IP several months back when the new CEO took over...duh... good sign that that would be a bad move... now they announce finalization of it.  And for...drum roll $107,000. 

Time for this skank CEO to go back to sorting there mail

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities